Clinical Trial Update: Epirubicin for the Treatment of Sepsis & Septic Shock [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating epirubicin for sepsis and septic shock is ongoing with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Drugs mentioned

• Epirubicin (epirubicin)

Snippet

Sponsor: Jena University Hospital | Conditions: Sepsis | Phase 2 | Status: UNKNOWN